1
|
Eaden JA, Abrams KR and Mayberry JF: The
risk of colorectal cancer in ulcerative colitis: a meta-analysis.
Gut. 48:526–535. 2001. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zisman TL and Rubin DT: Colorectal cancer
and dysplasia in inflammatory bowel disease. World J Gastroenterol.
14:2662–2669. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gupta RB, Harpaz N, Itzkowitz S, Hossain
S, Matula S, Kornbluth A, Bodian C and Ullman T: Histologic
inflammation is a risk factor for progression to colorectal
neoplasia in ulcerative colitis: a cohort study. Gastroenterology.
133:1099–1105. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Watanabe T, Kobunai T, Toda E, et al: Gene
expression signature and the prediction of ulcerative
colitis-associated colorectal cancer by DNA microarray. Clin Cancer
Res. 13:415–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Fujii S, Tominaga K, Kitajima K, et al:
Methylation of the oestrogen receptor gene in non-neoplastic
epithelium as a marker of colorectal neoplasia risk in longstanding
and extensive ulcerative colitis. Gut. 54:1287–1292. 2005.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Nishikawa M, Oshitani N, Matsumoto T,
Nishigami T, Arakawa T and Inoue M: Accumulation of mitochondrial
DNA mutation with colorectal carcinogenesis in ulcerative colitis.
Br J Cancer. 93:331–337. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Bartsch H and Nair J: Chronic inflammation
and oxidative stress in the genesis and perpetuation of cancer:
role of lipid peroxidation, DNA damage, and repair. Langenbecks
Arch Surg. 391:499–510. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Boman BM and Huang E: Human colon cancer
stem cells: a new paradigm in gastrointestinal oncology. J Clin
Oncol. 26:2828–2838. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Vermeulen L, Sprick MR, Kemper K, Stassi G
and Medema JP: Cancer stem cells – old concepts, new insights. Cell
Death Differ. 15:947–958. 2008.
|
10
|
Shipitsin M and Polyak K: The cancer stem
cell hypothesis: in search of definitions, markers, and relevance.
Lab Invest. 88:459–463. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Liang J, Wan M, Zhang Y, et al: Nanog and
Oct4 associate with unique transcriptional repression complexes in
embryonic stem cells. Nat Cell Biol. 10:731–739. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Tai MH, Chang CC, Kiupel M, Webster JD,
Olson LK and Trosko JE: Oct4 expression in adult human stem cells:
evidence in support of the stem cell theory of carcinogenesis.
Carcinogenesis. 26:495–502. 2005.PubMed/NCBI
|
13
|
Wang J, Levasseur DN and Orkin SH:
Requirement of Nanog dimerization for stem cell self-renewal and
pluripotency. Proc Natl Acad Sci USA. 105:6326–6331. 2008.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Horst D, Kriegl L, Engel J, Kirchner T and
Jung A: CD133 expression is an independent prognostic marker for
low survival in colorectal cancer. Br J Cancer. 99:1285–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Bijwaard KE, Aguilera NS, Monczak Y,
Trudel M, Taubenberger JK and Lichy JH: Quantitative real-time
reverse transcription-PCR assay for cyclin D1 expression: utility
in the diagnosis of mantle cell lymphoma. Clin Chem. 47:195–201.
2001.PubMed/NCBI
|
16
|
Lanzoni G, Roda G, Belluzzi A, Roda E and
Bagnara GP: Inflammatory bowel disease: Moving toward a stem
cell-based therapy. World J Gastroenterol. 14:4616–4626. 2008.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
18
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
19
|
Ieta K, Tanaka F, Haraguchi N, et al:
Biological and genetic characteristics of tumor-initiating cells in
colon cancer. Ann Surg Oncol. 15:638–648. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Brentnall TA, Crispin DA, Rabinovitch PS,
et al: Mutations in the p53 gene: an early marker of neoplastic
progression in ulcerative colitis. Gastroenterology. 107:369–378.
1994.PubMed/NCBI
|
21
|
Tarmin L, Yin J, Harpaz N, et al:
Adenomatous polyposis coli gene mutations in ulcerative
colitis-associated dysplasias and cancers versus sporadic colon
neoplasms. Cancer Res. 55:2035–2038. 1995.PubMed/NCBI
|
22
|
Chaubert P, Benhattar J, Saraga E and
Costa J: K-ras mutations and p53 alterations in neoplastic and
nonneoplastic lesions associated with longstanding ulcerative
colitis. Am J Pathol. 144:767–775. 1994.PubMed/NCBI
|
23
|
Farrell RJ and Peppercorn MA: Ulcerative
colitis. Lancet. 359:331–340. 2002. View Article : Google Scholar : PubMed/NCBI
|
24
|
Matsumoto T, Nakamura S, Jo Y, Yao T and
Iida M: Chromoscopy might improve diagnostic accuracy in cancer
surveillance for ulcerative colitis. Am J Gastroenterol.
98:1827–1833. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Rutter MD, Saunders BP, Schofield G,
Forbes A, Price AB and Talbot IC: Pancolonic indigo carmine dye
spraying for the detection of dysplasia in ulcerative colitis. Gut.
53:56–260. 2004. View Article : Google Scholar : PubMed/NCBI
|